•
Dr. Rundek is a collaborative clinical researcher with established extensive collaborations on these large NIH-funded studies at Columbia University (INVEST and U01 eMERGE), at Albert Einstein in the Bronx (Einstein Aging Study), and with national and international consortia (NINDS SiGN, ISGC, MRI-GENE).
•
Drs. Sacco and Rundek have an active genetic research program as a part of the Family Study with Dr. Blanton and Dr. Liyong Wang from the Miami Hussman Institute for Human Genomics (HIHG).
•
Drs. Sacco and Rundek participate and collaborate with the Hispanic Community Health Study- Study of Latinos (HCHS/SOL), which is a multi-site NIH contract.
•
Dr. Rundek collaborates with Mt. Sinai at Miami Beach, Florida International University (FIU) and Florida Atlantic University (FAU) on the Brain Vascular Imaging Phenotypes (VIP) study.
•
Dr. Rundek collaborates with UM CFAR (Center for AIDS Research). As a result of this collaboration, the HIV Aging Scientific Working Group (HIV SWG) was recently established under co-leadership of Dr. Rundek.
•
Dr. Della-Morte and Dr. Rundek are collaborating on a project aimed to evaluate the association between a well-established biomarker of systemic inflammation, the Arachidonic Acid/Eicosapentaenoic Acid (AA/EPA) ratio with biomarkers of carotid atherosclerosis and biomarkers of cognitive degeneration. A NIH R21 grant proposal is projected to be resubmitted after addressing the reviewers’ comments.
•
Dr. Della-Morte and Eng. Eugenio Martinelli launched as Co-Directors the IC-LOC (Interdisciplinary center for advanced studies on Lab-on-Chip and organ on-chip applications) Institute of Research at University of Tor Vergata, Rome.
50
